A Legislative History of the Federal Food, Drug, and Cosmetic Act and Its Amendments: TextU.S. Department of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1979 - Cosmetics |
From inside the book
Results 1-5 of 100
Page 109
... example , in electrical machinery General Electric is known to own about one - third of the stock of the leading German producer , AEG ( Algamine Electrical Gessellschaft ) , while International Tele- phone & Telegraph owns the majority ...
... example , in electrical machinery General Electric is known to own about one - third of the stock of the leading German producer , AEG ( Algamine Electrical Gessellschaft ) , while International Tele- phone & Telegraph owns the majority ...
Page 182
... example . 192 Chapter 12. The special problem of side effects .. 198 The case of Decadron .. 202 Advertising to physicians . 204 Testimony of Merck officials .. 207 The case of Diabinese ... 210 Opinion of medical experts . Pfizer data ...
... example . 192 Chapter 12. The special problem of side effects .. 198 The case of Decadron .. 202 Advertising to physicians . 204 Testimony of Merck officials .. 207 The case of Diabinese ... 210 Opinion of medical experts . Pfizer data ...
Page 188
... example , the public believes that unjustifiably high prices are wrong , the " corporate conscience " possessed by manage- ADMINISTERED PRICES - DRUGS 5 ments of firms in a 188 VOL . 17 LEGISLATIVE HISTORY OF THE FOOD , DRUG & COSMETIC ACT.
... example , the public believes that unjustifiably high prices are wrong , the " corporate conscience " possessed by manage- ADMINISTERED PRICES - DRUGS 5 ments of firms in a 188 VOL . 17 LEGISLATIVE HISTORY OF THE FOOD , DRUG & COSMETIC ACT.
Page 193
... example , relates to the activities of the company as a whole and can be divided among a company's various products only by some method of allocation . The same is true of selling expense which is generated by the effort to dispose of ...
... example , relates to the activities of the company as a whole and can be divided among a company's various products only by some method of allocation . The same is true of selling expense which is generated by the effort to dispose of ...
Page 197
... Poulenc , hearings , pt . 25 , pp . 14275. ( Italics added . ) American Druggist , Sept. 19 , 1960 . 14 ADMINISTERED PRICES DRUGS mittee's presentation . For example , 197 VOL . 17 LEGISLATIVE HISTORY OF THE FOOD , DRUG & COSMETIC ACT.
... Poulenc , hearings , pt . 25 , pp . 14275. ( Italics added . ) American Druggist , Sept. 19 , 1960 . 14 ADMINISTERED PRICES DRUGS mittee's presentation . For example , 197 VOL . 17 LEGISLATIVE HISTORY OF THE FOOD , DRUG & COSMETIC ACT.
Other editions - View all
Common terms and phrases
ADMINISTERED PRICES ADMINISTERED PRICES-DRUGS advertising amended American Cyanamid American Home Products antibiotics Antitrust Antitrust and Monopoly appear application Association Aureomycin bill bottle brand name Bristol capsules Carter cents chart chemical chloramphenicol Chloromycetin chlorpromazine chlorpropamide Committee competition Corp corticosteroids cortisone Cosmetic countries Davis Decadron dexamethasone Diabinese discovery doctors Drug Administration drug companies drug industry drug manufacturers drug products efficacy erythromycin ethical drugs Federal firms Food and Drug foreign prices Hearings hospital Ibid insulin Journal Laboratories license Lilly margin medicine ment meprobamate Merck million MMSA National Office Orinase packaging Parke penicillin percent Pfizer pharmaceutical pharmacists pharmacy physician prednisolone prednisone prescribed prescription president Price to druggist prochlorperazine product patents production costs profit promotion reported retail royalty Schering Secretary selling Senator KEFAUVER side effects sold Squibb steroid subcommittee subsection Syntex Table tablets tetracycline thereof tion tolbutamide trade name United Upjohn
Popular passages
Page 475 - ... may obtain judicial review by filing in the United States court of appeals for the circuit wherein such person resides or has his principal place of business, or in the United States Court of Appeals for the District of Columbia Circuit, within sixty days after the entry of such order, a petition praying that the order be set aside in whole or in part.
Page 250 - That, as we enjoy great advantages from the inventions of others, we should be glad of an opportunity to serve others by any invention of ours; and this we should do freely and generously.
Page 475 - ... a petition with the United States court of appeals for the circuit wherein such person resides or has his principal place of business, for a judicial review of such order.
Page 475 - The judgment of the court affirming or setting aside, in whole or in part, any action of the Secretary shall be final, subject to review by the Supreme Court of the United States upon certiorari or certification as provided in section 1254 of Title 28, United States Code.
Page 447 - People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or in some contrivance to raise prices.
Page 483 - Mr. President, I suggest the absence of a quorum. The PRESIDING OFFICER. The clerk will call the roll.
Page 12 - Mr. President, I ask unanimous consent that the order for the quorum call be rescinded. The PRESIDING OFFICER. Without objection, it is so ordered.
Page 75 - Judiciary, or any duly authorized subcommittee thereof, is authorized under sections 134 (a) and 136 of the Legislative Reorganization Act of 1946, as amended, and in accordance with its jurisdictions specified by rule XXV of the Standing Rules of the Senate, to...
Page 476 - USC 1003). (d) After each such review, and at such other times as the Secretary may determine to be necessary or desirable, the Secretary shall cause to be compiled, published, and publicly distributed a list which shall list all revised official names of drugs designated under this section and shall contain such descriptive and explanatory matter as the Secretary may determine to be required for the effective use of those names.
Page 307 - CHLOROMYCETIN is a potent therapeutic agent and, because certain blood dyscrasias have been associated with its administration, it should not be used indiscriminately or for minor infections. Furthermore, as with certain other drugs, adequate blood studies should be made when the patient requires prolonged or intermittent therapy.